Nantahala Capital Management »

Aprea Therapeutics shares owned by Nantahala Capital Management

Quarter-by-quarter ownership of Aprea Therapeutics (APRE) shares owned by Nantahala Capital Management from 13F filings

Historical chart of Nantahala Capital Management investment in Aprea Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aprea Therapeutics held by Nantahala Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aprea Therapeutics by Nantahala Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $837k 206k 4.07
2024-03-31 $1.4M 206k 6.69

More positions owned by Nantahala Capital Management

Ishares Tr Russell 2000 Etf (IWM)
Ishares Tr Russell 2000 Etf (IWM)
Eli Lilly & Co. Put Option (LLY)
Eli Lilly & Co. Put Option (LLY)
Soleno Therapeutics (SLNO)
Soleno Therapeutics (SLNO)
Establishment Labs Holdings Ord (ESTA)
Establishment Labs Holdings Ord (ESTA)
Spdr Ser Tr S&p Biotech (XBI)
Spdr Ser Tr S&p Biotech (XBI)
Peloton Interactive Cl A Com (PTON)
Peloton Interactive Cl A Com (PTON)
Grand Canyon Education Put Option (LOPE)
Grand Canyon Education Put Option (LOPE)
Imax Corp Cad (IMAX)

View all positions for Nantahala Capital Management

Top funds holding Aprea Therapeutics

AIGH Capital Management
Sio Capital Management
Sphera Funds Management
Nantahala Capital Management
Altium Capital Management
DAFNA Capital Management
Exome Asset Management
Stonepine Capital Management
Vanguard Group
Geode Capital Management
Morgan Stanley
Dimensional Fund Advisors
HighTower Advisors
Susquehanna International
BlackRock

View all funds holding Aprea Therapeutics